allan l shaw joins syndax pharmaceuticals as chief financial officer allan l shaw joins syndax pharmaceuticals as chief financial officer jan  6  et from syndax pharmaceuticals inc waltham mass jan  6 prnewswire  syndax pharmaceuticals inc a clinical stage biopharmaceutical company focused on developing entinostat in multiple cancer indications announced today that the company has appointed allan l shaw as chief financial officer treasurer and secretary mr shaw joins syndax with more than  years of experience as a chief financial officer industry executive and independent board member of public companies we are very pleased to welcome allan to the syndax senior management team during an exciting period for the company his breadth of experience including corporate finance capital markets and strategic transactions will be critical in financing and supporting our business initiatives as we continue to develop our lead candidate entinostat in multiple cancer indications and expand our clinical pipeline said briggs w morrison md chief executive officer of syndax allan further strengthens our management team as he brings more than two decades of public company financial operational and strategic global business leadership to the company said michael a metzger president and chief operating officer of syndax in this role he will be instrumental in working with the investment community to help build the broadest awareness of syndax and support the growth of our organization mr shaw is a threetime public company chief financial officer with proven skills across multiple finance disciplines and he has a broad base of expertise in corporate governance and risk management most recently mr shaw served as a managing director of alvarez  marsal a global professional services firm and led their biopharmaceutical consulting practice he currently serves on the boards of directors of two public companies vivus inc and akari therapeutics plc mr shaws previous experience includes serving as the chief financial officer of serono sa newlead holdings ltd and viatel inc mr shaw was also the founder and senior managing director of shaw strategic capital llc an international financial advisory firm focused on providing strategic financial counsel on a wide variety of issues such as general corporate finance mergers and acquisitions capital structuring licensing and capital markets mr shaw received a bs from the state university of new york at oswego and is a certified public accountant in the state of new york  mr shaw added syndax is an exciting innovative company with tremendous potential and i share its vision to advance effective and safe medicines that address the unmet medical needs of cancer patients i am looking forward to working closely with the other members of this very talented management team to help maximize entinostats vast potential and expand our oncology drug pipeline about syndax pharmaceuticals inc syndax is a clinical stage biopharmaceutical company developing entinostat as a combination therapy in multiple cancer indications with an initial focus on tumors that have shown sensitivity to immunotherapy including lung cancer melanoma ovarian cancer and triplenegative breast cancer tnbc entinostat is an oral small molecule drug candidate that has direct effects on both cancer cells and immune regulatory cells potentially enhancing the bodys immune response to tumors entinostat is being evaluated as a combination therapeutic in phase b clinical trials with merck  co inc for nonsmall cell lung cancer and melanoma with genentech inc for tnbc and with merck kgaa darmstadt germany and pfizer inc in ovarian cancer syndax is also developing entinostat as a combination therapeutic in a phase  clinical trial that is being conducted with ecogacrin for advanced hormone receptor positive breast cancer for more information on syndax please visit wwwsyndaxcom investor and media contacts karen l bergmanbcc partners 9kbergmanbccpartnerscom jen lavinbcc partners 6 jlavinbccpartnerscom source syndax pharmaceuticals inc related links httpwwwsyndaxcom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more jul   6 et preview preclinical results support entinostats role in targeting the tumor microenvironment to enhance immune checkpoint therapy dec    et preview syndax announces multiple data presentations on entinostat at upcoming san antonio breast cancer symposium my news release contains wide tables view fullscreen read more jul   6 et preclinical results support entinostats role in targeting the more news releases in biotechnology health care  hospitals medical pharmaceuticals personnel announcements looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search allan l shaw homecorporate informationmanagement teamboard of directorscareerssearch open positionscontact usvivus oag supply chains act compliance statementproductsuseuclinical trialsmedical affairsrems programmedical education grantsmedical informationrequest medical informationinvestigatorinitiated trialsae  pc reportingnewsroompress releaseslogo downloadsinvestorspress releasesevents and presentationscorporate governancefinancial informationstock informationinvestors faqcontactemail usemail usmaps  directions you are here home  corporate information  board of directors  allan l shaw board of directors allan l shaw allan l shaw has served as a director of the company since september   from january 6 to february  mr shaw was the chief financial officer and treasurer of syndax pharmaceuticals inc a publicly listed clinical stage biopharmaceutical company mr shaw was managing director of alvarez  marsal llc a global professional services firm and led their biopharmaceutical consulting practice from december  to march  and supported the firm on an ad hoc basis from march  to october  from 9 to  he served as the chief financial officer of newlead holdings ltd a publicly traded global shipping company from  to 9 he was the founder and senior managing director of shaw strategic capital llc an international financial advisory firm focused on providing strategic financial counsel on a wide variety of issues such as general corporate finance mergers and acquisitions capital structuring licensing and capital markets from  to  mr shaw was the chief financial officer of serono sa a publicly traded global biotechnology company and from  to  he was the chief financial officer of viatel inc a publicly traded international communications company mr shaw serves on the board of directors of edith  carl marks jch of bensonhurst a nonprofit organization he also served on the board of directors of akari therapeutics plc from  to 6 the central new york biotech accelerator formerly central new york—biotech research center from 9 to  newlead holdings ltd from 9 to  navios maritime holdings inc from  to  serono sa as an executive management board member from  to  and viatel inc from 6 to  he has contributed to several corporate governance books and is a member of the american institute of certified public accountants new york society of certified public accountants and corporate directors group mr shaw received a bs from the state university of new york oswego college and is a certified public accountant in the state of new york mr shaw’s qualifications as a director include his extensive leadership experience as a chief financial officer his diverse industry background in companies of ranging sizes and his broad base of expertise with capital markets and operational expertise with a view toward corporate governance risk management and leadership in this section management teamboard of directorscareerscontact usvivus oag supply chains act compliance statement board of directors seth h z fischer david york norton thomas b king jorge plutzky md eric w roberts herman rosenman allan l shaw useful resources contact usinfo request logo downloads management team   vivus inc all rights reserved contactsitemapprivacy policyterms of usesite by formative shaw allan restorations in sacramento ca 96  chamberofcommercecom  sign up sign in contact us   search   near   home » california » sacramento » auto body shops » shaw allan restorations shaw allan restorations  reviews  stars  based on  reviews 9 ballantine st sacramento california 96 96 6     print  save  directions about shaw allan restorations is located at the address 9 ballantine st in sacramento california 96 they can be contacted via phone at 96 6 for pricing hours and directions shaw allan restorations specializes in domestic motorcycles credit problems shaw allan restorations provides installations showroom vacuuming to its customers for maps and directions to shaw allan restorations view the map to the right for reviews of shaw allan restorations see below business features products electrical parts  radiators  wreckers  engines  lowering kits  seat covers  glass  hoses  hitches  custom wheels services laminating  vacuuming  showroom  gift certificates  imaging  installation  exhaust systems  oil changes  installations  diagnostics brands audi  toyota  bridgestone  midas  cadillac  michelin  lexus  corvette  dunlop  hummer specialties insurance claims  classic  german  credit problems  motorcycles  imports  domestic  commercial vehicles  hail damage  luxury   information contact information phone 96 6 additional information main contact first name allan main contact last name shaw main contact title owner categories auto body shops repair  maintenance auto repair people also viewed pettinatos body shop inc  th st sacramento california 9 image paint  body  th ave sacramento california 9 golden auto body  fender  la grande blvd sacramento california 9 conovers car care  princeton st sacramento california 9 new saigon auto collision center 66 stockton blvd sacramento california 9 duanes body  paint  belleau wood ln sacramento california 9 reviews add you must sign in to post reviews by on click here to be the first to review this business  reviews     site map faq privacy policy terms of use about partners chamber partner program chamber member benefits top cities atlanta bronx brooklyn chicago cleveland dallas denver detroit houston las vegas los angeles miami minneapolis new york philadelphia phoenix saint louis san antonio san diego san jose   chamberofcommercecom allan block dealer shaw brickdartmouth homeowners  contractors  designers find a store  photo gallery  video gallery products catalogs installation estimating project faqs ↰ back to locator products about contact us shaw brickdartmouth 9 9    dartmouthshawbrickca    product specialists ab experts shaun fitzgerald store hours week days  am   pmsaturday  am   pm may thru oct onlysunday closed  ralston ave dartmouth nova scotia  map  directions how are we doingwed love to hear your feedback our products back to top ↑ ab® collection more details ab europa® collection more details ab courtyard collection® more details ab garden collection® more details our allan block products are manufactured by shaw brick other specialties brick masonry stone masonry concrete masonry retaining walls patio walls garden walls natural stone pavers about us back to top ↑ shaw brickdartmouth shaw brick is an atlantic canadian based manufacturer of quality clay masonry and concrete landscape products building on a tradition established in 6 shaw brick continues to blend traditional values and innovative solutions to offer a variety of brick collections and stone products that will add an exclusive dimension to the design of your home shaw brick’s durable landscape products add elegance and appeal to any outdoor living space the versatility and array of shapes colours and patterns available in driveway  walkway pavers garden walls landscape walls and retaining wall systems offer you unlimited design possibilities contact us back to top ↑ shaw brickdartmouth  ralston ave dartmouth nova scotia bb hcanada visit our website 9 9 questions or comments for shaw brickdartmouth please answer the question below to help us avoid spam you have six blocks and zero more are added how many blocks do you have   zero one two three four five six seven eight nine ten eleven twelve thirteen fourteen fifteen sixteen seventeen eighteen nineteen twenty shaw allan dr  philadelphia pa  company information products resources my account talk to a db advisor  business directory pa philadelphia offices and clinics of dentists offices and clinics of dentists shaw allan dr s shaw allan dr claim this business 6 walnut st ste 6 philadelphia pa 9 get directions  6 business info founded  incorporated annual revenue  employee count  industries offices and clinics of dentists contacts allan shaw contact business your email address subject message send message verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   s view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved allan w shaw  angleton tx  company information products resources my account talk to a db advisor  business directory tx angleton nonclassifiable establishments nonclassifiable establishments allan w shaw a allan w shaw claim this business angleton tx 6 get directions business info founded  incorporated annual revenue  employee count  industries nonclassifiable establishments contacts  contact business your email address subject message send message verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   a view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved tile and stone wall and flooring tiles  shaw floors search for shaw floors tile  stone flooring so beautiful you’ll watch every step sleek styles in a variety of breathtaking colors and patterns stellar x brick  limestone get product details pin it catalog sort by featured newest az za featured filter color texture type application compare compare up to  swatches clear all submit style  color combinations refine  swatch view room view samples available the comfort of tile  stone see shaws full tile  stone catalog  apply results clear samples available clear filters color grey brown rustcopper white red beigetan black green look mosaic stone subway  rectangle wood type ceramic glass limestone marble metal mixed media natural stone pebble  river rock porcelain slate travertine application accent countertop exteriors floor trim  bullnose wall color trends lady in grey the color that is captivating designers all year long play flooring fundamentals why tile  stone see the many benefits of tile  stone flooring benefits of tile  stone installation get the advice you need for the best installation about tile  stone installation cleaning tile  stone tile and stone floors are perhaps the easiest type of floor to keep clean sweeping dusting or vacuuming your floor regularly removes the accumulation of dirt or grit that can scratch the surface download cleaning  maintenance guides tile  stone care and maintenance preventative maintenance to keep your floors looking great preventative care for tile  stone why shaw why shaw our style quality and design are rated no  year after year see how local retailers across the country rate our products and service see more reasons why subscribe to our newsletter stay uptodate on the latest design trends new products and special deals on the best flooring around dont worry we wont fill your inbox and well never send you spam i accept shaws terms and conditions i accept shaws privacy policy thank you youre now signed up to receive updates from shaw and whether youre looking to gather information select a new style or care for the floors in your home we look forward to helping you along the way in the meantime stay organized by creating a my shaw account where you can compare your flooring options save your favorites and keep track of your orders all in one place sure sign me up management  calysta managementyou are here home  company  management management alan shaw phd president and ceo alan shaw phd is president and chief executive officer of calysta and a member of the board of directors he joined in  dr shaw is a veteran biotechnology entrepreneur and chemical industry executive with more than  years experience building and leading technology companies before joining calysta he served for ten years as president  ceo and a director of codexis a developer of costadvantaged processes for production of biobased chemicals and pharmaceuticals during his tenure codexis completed an ipo and expanded from a startup to a global industrial biotechnology company with operations in the united states europe and asia in  dr shaw received the ernst and young entrepreneur® of the year award in the life sciences category for northern california he is a member of the board of directors of bio and the governing board of the bio industrial and environmental section he also serves as a biotechnology advisor to the governments of the united kingdom and malaysia and is a frequent speaker at leading business and industry conferences prior to codexis dr shaw held senior operating and business development positions in the united kingdom for chiroscience group plc and for the chemical and biopharmaceutical units of clariant and btp plc from  for the previous  years he held management and scientific leadership positions for imperial chemical industries plc icizeneca including business head fine chemicals and marketing manager european sales he holds a bachelor’s degree in chemistry from teesside university and a phd in chemistry from the university of durham england he is a fellow of the royal society of chemistry and a fellow of the chartered institute of marketing graham aylen vice president global capital projects graham aylen cengis vice president for global capital projects at calysta and managing director of calysta uk limited mr aylen joined calysta in  working on the acquisition of calysta as in norway he currently focuses on the delivery of the small scale facility project in the united kingdom and the commercialization of feedkind™ protein prior to joining calysta he held positions where he was responsible for the safe delivery of large scale capital projects in the fine chemical pharmaceutical and biotechnology industries internationally with ici zeneca avecia costain gsk pfizer anglian water and codexis mr aylen has also worked on professional committees developing policy with the uk and malaysian government and the icheme tomas belloso phd vice president regulatory affairs tomas belloso phd joined calysta as vice president regulatory affairs in 6 he reports to josh silverman phd chief product and innovation officer and is responsible for the company’s regulatory and quality management programs and strategy dr belloso has over a decade of senior regulatory quality and product management experience in the feed and animal health industries before joining calysta he served as regulatory compliance manager at the feed division of wilburellis a  billion international marketer and distributor of agricultural products animal feed and specialty chemicals and ingredients prior to that he held senior regulatory and product management positions at royal canin usa a subsidiary of mars inc nestle purina monsanto and elanco animal health he holds a phd in animal sciences and a master’s degree in dairy sciences from the university of florida and a bachelor’s degree in animal sciences from universidad rafael urdaneta in venezuela blake campbell general counsel blake campbell joined calysta in 6 as the company’s general counsel he has responsibility for the company’s global legal strategy planning and management prior to calysta mr campbell served as general counsel for extend health inc and alphaimpactrx inc and as a senior attorney for several global law firms mr campbell has also served as a senior adviser to former california senator and governor pete wilson in washington dc and sacramento mr campbell specializes in general corporate and finance matters and has extensive experience with project finance transactions strategic and crossborder transactions technology transfers joint development and strategic ip licensing and portfolio management mergers and acquisitions initial public offerings venture financings executive compensation board and committee support and governance secsoxnasdaq compliance and reporting and risk and litigation management mr campbell holds a bachelor of arts from stanford university and a jd from the university of california at los angeles lori giver phd vice president biological engineering lori giver phd is the vice president of biological engineering at calysta she joined calysta in  and is responsible for rd staff and project management prior to joining the company lori was with codexis inc where she held a number of positions including vice president of systems biology senior directory of technology and innovation and manager of market development prior to codexis she was head of the core technology group at maxgyen inc dr giver has focused her career on the directed evolution of nucleic acids proteins and organisms she has chaired several conferences in the field including enzyme engineering xxi and applications for enzyme technologies  she is an author on more than  scientific publications and over  patents and patent applications she received a bachelor of science degree in molecular and cell biology from the university of californiaberkeley and phd in molecular cell and developmental biology from indiana university bloomington dr giver did her postdoctoral research at the california institute of technology in the laboratory of dr frances arnold allan leblanc senior director and feedkind® product manager allan leblanc is senior director and feedkind product manager he was named to his current position in  and previously served as product manager feedkind® he is responsible for global market and sales strategy of calysta nutritional products including prioritization by geography and species he also provides market intelligence guiding future product development mr leblanc joined calysta in  as director of corporate development where he worked on fundraising the acquisition of bioprotein as and financial planning and analysis prior to joining calysta mr leblanc worked in venture capital at ballast point ventures where he focused on the pharmaceutical and healthcare industry he also has prior experience in investment banking at raymond james where he worked on both mergers and acquisitions and public equity offerings for airlines and environmental services companies mr leblanc holds an mba from the university of californiaberkeley’s haas school of business and a bachelor of science degree from the university of florida dennis leong vice president business development mr leong joined calysta in  he has responsibility for all business development strategy and program execution including broadening the calysta portfolio of strategic partnerships he joined calysta from chemtex an international technology and engineering organization where he was the executive vice president responsible for worldwide marketing and business development at chemtex he played an integral role in building the renewable and sustainable products business including launching and licensing beta renewables’ cellulosic ethanol technology before joining chemtex in  mr leong led the marketing and business development activities for the downstream petrochemical and chemical business of aker solutions a global engineering and construction contractor over his  year tenure with the group he was based in a number of international locations including canada japan hong kong singapore and the united kingdom he holds a bachelor of applied science degree in chemical engineering from the university of british columbia and is a registered professional engineer in canada josh silverman phd chief product and innovation officer josh silverman phd is calysta’s chief product and innovation officer and founder he was appointed to his current position in 6 dr silverman served as calysta’s chief technology officer from 6 and prior to that served as chief scientific officer dr silverman is an experienced biotechnology entrepreneur with a history of successful development of novel technology platforms prior to founding calysta dr silverman held positions at two public biotechnology companies maxygen inc and amgen inc as well as serving as vp of product development for amunix inc he has been involved in the founding and financing of five startup biotechnology companies avidia versartis diartis siluria and calysta his efforts contributed to raising over  million in equity financing across these companies as well as the sale of avidia for 9m three years after founding the company and an ipo by versartis in  which raised 6 million dr silverman is generally interested in tools and applications of biological engineering as a robust and predictable engineering discipline he serves as an advisor for a number of biotechnology companies and is a frequent speaker at scientific meetings he has been directly involved in successfully bringing three novel biopharmaceuticals from early phase research into clinical trials with experience in both regulatory filings and drug manufacturing he is an author on more than  scientific publications as well as over  patents and pending patent applications he received his bsc in molecular biology from uc san diego and phd in biochemistry from stanford university lynsey wenger chief financial officer and chief sustainability officer lynsey wenger joined calysta in 6 as chief financial officer and chief sustainability officer she is responsible for the company’s financial strategy planning and management and for expansion and implementation of calysta’s long term sustainability strategy and programs ms wenger joined calysta following a 6year career with the goldman sachs group where she spent the greater part of the last decade specializing in global natural resources investment banking she will have responsibility for the company’s financial strategy planning and management and for expansion and implementation of calysta’s long term sustainability strategy and programs during ms wenger’s career at goldman sachs she managed and led investment banking activities in global natural resources ranging from international mergers and acquisitions and ipos to multimilliondollar equity transactions and debt placements her industry experience includes natural gas and electric utilities power renewables and alternative energy most recently ms wenger served as a vice president in the investment banking division with responsibility for transactions in the corporate power and utility sectors previously she served in the americas financing group as head of investment grade power utility and midstream debt capital markets earlier in her career she held positions in equity derivative sales in the united states and australia ms wenger holds an mba from the wharton school at the university of pennsylvania and a bachelor of arts degree from duke university kumiko yoshinari phd cfa director project finance kumiko yoshinari phd cfa joined calysta as director project finance in 6 she has responsibility for the company’s project development and finance dr yoshinari served for nearly  years at the international finance corporation ifc a unit of the world bank group at ifc she structured more than  investment transactions valued at over  billion in asia europe and africa she served as principal advisor sustainable energy finance with responsibility for financing transactions in renewable energy and energy efficiency she also held a variety of other positions including principal strategist and division manager for east asia just prior to joining calysta dr yoshinari originated developed and structured financings for solar powerenergy storage and wind power projects jointly with her business partners dr yoshinari holds a bachelor’s degree in economics from the university of washington a master’s degree in public policy from harvard university and a phd in applied economics from the universite de paris ix she is also a chartered financial analyst companymanagement alan shaw phd graham aylen tomas belloso phd blake campbell lori giver phd allan leblanc dennis leong josh silverman phd lynsey wenger kumiko yoshinari board advisory board locations ​ management  calysta managementyou are here home  company  management management alan shaw phd president and ceo alan shaw phd is president and chief executive officer of calysta and a member of the board of directors he joined in  dr shaw is a veteran biotechnology entrepreneur and chemical industry executive with more than  years experience building and leading technology companies before joining calysta he served for ten years as president  ceo and a director of codexis a developer of costadvantaged processes for production of biobased chemicals and pharmaceuticals during his tenure codexis completed an ipo and expanded from a startup to a global industrial biotechnology company with operations in the united states europe and asia in  dr shaw received the ernst and young entrepreneur® of the year award in the life sciences category for northern california he is a member of the board of directors of bio and the governing board of the bio industrial and environmental section he also serves as a biotechnology advisor to the governments of the united kingdom and malaysia and is a frequent speaker at leading business and industry conferences prior to codexis dr shaw held senior operating and business development positions in the united kingdom for chiroscience group plc and for the chemical and biopharmaceutical units of clariant and btp plc from  for the previous  years he held management and scientific leadership positions for imperial chemical industries plc icizeneca including business head fine chemicals and marketing manager european sales he holds a bachelor’s degree in chemistry from teesside university and a phd in chemistry from the university of durham england he is a fellow of the royal society of chemistry and a fellow of the chartered institute of marketing graham aylen vice president global capital projects graham aylen cengis vice president for global capital projects at calysta and managing director of calysta uk limited mr aylen joined calysta in  working on the acquisition of calysta as in norway he currently focuses on the delivery of the small scale facility project in the united kingdom and the commercialization of feedkind™ protein prior to joining calysta he held positions where he was responsible for the safe delivery of large scale capital projects in the fine chemical pharmaceutical and biotechnology industries internationally with ici zeneca avecia costain gsk pfizer anglian water and codexis mr aylen has also worked on professional committees developing policy with the uk and malaysian government and the icheme tomas belloso phd vice president regulatory affairs tomas belloso phd joined calysta as vice president regulatory affairs in 6 he reports to josh silverman phd chief product and innovation officer and is responsible for the company’s regulatory and quality management programs and strategy dr belloso has over a decade of senior regulatory quality and product management experience in the feed and animal health industries before joining calysta he served as regulatory compliance manager at the feed division of wilburellis a  billion international marketer and distributor of agricultural products animal feed and specialty chemicals and ingredients prior to that he held senior regulatory and product management positions at royal canin usa a subsidiary of mars inc nestle purina monsanto and elanco animal health he holds a phd in animal sciences and a master’s degree in dairy sciences from the university of florida and a bachelor’s degree in animal sciences from universidad rafael urdaneta in venezuela blake campbell general counsel blake campbell joined calysta in 6 as the company’s general counsel he has responsibility for the company’s global legal strategy planning and management prior to calysta mr campbell served as general counsel for extend health inc and alphaimpactrx inc and as a senior attorney for several global law firms mr campbell has also served as a senior adviser to former california senator and governor pete wilson in washington dc and sacramento mr campbell specializes in general corporate and finance matters and has extensive experience with project finance transactions strategic and crossborder transactions technology transfers joint development and strategic ip licensing and portfolio management mergers and acquisitions initial public offerings venture financings executive compensation board and committee support and governance secsoxnasdaq compliance and reporting and risk and litigation management mr campbell holds a bachelor of arts from stanford university and a jd from the university of california at los angeles lori giver phd vice president biological engineering lori giver phd is the vice president of biological engineering at calysta she joined calysta in  and is responsible for rd staff and project management prior to joining the company lori was with codexis inc where she held a number of positions including vice president of systems biology senior directory of technology and innovation and manager of market development prior to codexis she was head of the core technology group at maxgyen inc dr giver has focused her career on the directed evolution of nucleic acids proteins and organisms she has chaired several conferences in the field including enzyme engineering xxi and applications for enzyme technologies  she is an author on more than  scientific publications and over  patents and patent applications she received a bachelor of science degree in molecular and cell biology from the university of californiaberkeley and phd in molecular cell and developmental biology from indiana university bloomington dr giver did her postdoctoral research at the california institute of technology in the laboratory of dr frances arnold allan leblanc senior director and feedkind® product manager allan leblanc is senior director and feedkind product manager he was named to his current position in  and previously served as product manager feedkind® he is responsible for global market and sales strategy of calysta nutritional products including prioritization by geography and species he also provides market intelligence guiding future product development mr leblanc joined calysta in  as director of corporate development where he worked on fundraising the acquisition of bioprotein as and financial planning and analysis prior to joining calysta mr leblanc worked in venture capital at ballast point ventures where he focused on the pharmaceutical and healthcare industry he also has prior experience in investment banking at raymond james where he worked on both mergers and acquisitions and public equity offerings for airlines and environmental services companies mr leblanc holds an mba from the university of californiaberkeley’s haas school of business and a bachelor of science degree from the university of florida dennis leong vice president business development mr leong joined calysta in  he has responsibility for all business development strategy and program execution including broadening the calysta portfolio of strategic partnerships he joined calysta from chemtex an international technology and engineering organization where he was the executive vice president responsible for worldwide marketing and business development at chemtex he played an integral role in building the renewable and sustainable products business including launching and licensing beta renewables’ cellulosic ethanol technology before joining chemtex in  mr leong led the marketing and business development activities for the downstream petrochemical and chemical business of aker solutions a global engineering and construction contractor over his  year tenure with the group he was based in a number of international locations including canada japan hong kong singapore and the united kingdom he holds a bachelor of applied science degree in chemical engineering from the university of british columbia and is a registered professional engineer in canada josh silverman phd chief product and innovation officer josh silverman phd is calysta’s chief product and innovation officer and founder he was appointed to his current position in 6 dr silverman served as calysta’s chief technology officer from 6 and prior to that served as chief scientific officer dr silverman is an experienced biotechnology entrepreneur with a history of successful development of novel technology platforms prior to founding calysta dr silverman held positions at two public biotechnology companies maxygen inc and amgen inc as well as serving as vp of product development for amunix inc he has been involved in the founding and financing of five startup biotechnology companies avidia versartis diartis siluria and calysta his efforts contributed to raising over  million in equity financing across these companies as well as the sale of avidia for 9m three years after founding the company and an ipo by versartis in  which raised 6 million dr silverman is generally interested in tools and applications of biological engineering as a robust and predictable engineering discipline he serves as an advisor for a number of biotechnology companies and is a frequent speaker at scientific meetings he has been directly involved in successfully bringing three novel biopharmaceuticals from early phase research into clinical trials with experience in both regulatory filings and drug manufacturing he is an author on more than  scientific publications as well as over  patents and pending patent applications he received his bsc in molecular biology from uc san diego and phd in biochemistry from stanford university lynsey wenger chief financial officer and chief sustainability officer lynsey wenger joined calysta in 6 as chief financial officer and chief sustainability officer she is responsible for the company’s financial strategy planning and management and for expansion and implementation of calysta’s long term sustainability strategy and programs ms wenger joined calysta following a 6year career with the goldman sachs group where she spent the greater part of the last decade specializing in global natural resources investment banking she will have responsibility for the company’s financial strategy planning and management and for expansion and implementation of calysta’s long term sustainability strategy and programs during ms wenger’s career at goldman sachs she managed and led investment banking activities in global natural resources ranging from international mergers and acquisitions and ipos to multimilliondollar equity transactions and debt placements her industry experience includes natural gas and electric utilities power renewables and alternative energy most recently ms wenger served as a vice president in the investment banking division with responsibility for transactions in the corporate power and utility sectors previously she served in the americas financing group as head of investment grade power utility and midstream debt capital markets earlier in her career she held positions in equity derivative sales in the united states and australia ms wenger holds an mba from the wharton school at the university of pennsylvania and a bachelor of arts degree from duke university kumiko yoshinari phd cfa director project finance kumiko yoshinari phd cfa joined calysta as director project finance in 6 she has responsibility for the company’s project development and finance dr yoshinari served for nearly  years at the international finance corporation ifc a unit of the world bank group at ifc she structured more than  investment transactions valued at over  billion in asia europe and africa she served as principal advisor sustainable energy finance with responsibility for financing transactions in renewable energy and energy efficiency she also held a variety of other positions including principal strategist and division manager for east asia just prior to joining calysta dr yoshinari originated developed and structured financings for solar powerenergy storage and wind power projects jointly with her business partners dr yoshinari holds a bachelor’s degree in economics from the university of washington a master’s degree in public policy from harvard university and a phd in applied economics from the universite de paris ix she is also a chartered financial analyst companymanagement alan shaw phd graham aylen tomas belloso phd blake campbell lori giver phd allan leblanc dennis leong josh silverman phd lynsey wenger kumiko yoshinari board advisory board locations ​ company  calysta  innovative and sustainable industrial products companyyou are here home  company company creating value through innovation calysta is an innovator in sustainable products to improve worldwide food security calysta is developing and commercializing feedkind® protein a sustainable traceable alternative feed ingredient for fish livestock and pet nutritional products companymanagement board advisory board investors locations ​